Stocktoria
Lifevantage Corp LFVN
Lifevantage Corp (LFVN) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the distress zone. It pays a dividend yielding 2.47% (safety: safe). FY2025 revenue was $228.5M at a 4.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.54 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.329 |
| Retained earnings / assets | -1.447 |
| EBIT / assets | 0.17 |
| Equity / liabilities | 0.928 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| LFVN | Lifevantage Corp | 6/9 | -0.45 | 8.5 | +14.2% |
| PBYI | PUMA BIOTECHNOLOGY, INC. | 6/9 | -14.13 | 13.3 | -0.9% |
| ANAB | ANAPTYSBIO, INC | 5/9 | -0.3 | — | +157% |
| AKBA | Akebia Therapeutics, Inc. | 5/9 | -12.49 | — | +47.5% |
| IDYA | IDEAYA Biosciences, Inc. | 3/9 | 12.9 | — | — |
| VNDA | Vanda Pharmaceuticals Inc. | 2/9 | 0.13 | — | +8.7% |
| AMRN | AMARIN CORP PLCUK | 5/9 | -2.07 | — | -6.5% |
About Lifevantage Corp
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.
FAQ
Is LFVN financially healthy?
Lifevantage Corp's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does LFVN pay a dividend, and is it safe?
Yes. Lifevantage Corp pays a dividend yielding about 2.47% with a 21.1% payout ratio, rated “safe” for safety.
How profitable is LFVN?
In FY2025, Lifevantage Corp had a net margin of 4.3% and a return on equity of 28.3%.
Is LFVN overvalued or undervalued?
Lifevantage Corp trades at about 8.7× trailing earnings — below its 10-year norm (10-year range 9.0×–35.6×, median 23.6×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for LFVN?
The average Wall-Street price target for Lifevantage Corp is $7.00, about 7.5% above the recent price, from 2 analysts.
Is LFVN a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Lifevantage Corp: a Piotroski F-score of 6/9, an Altman Z″ in the distress zone, a P/E of about 8.5×, a dividend yield of 2.47%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.